secwatch.observer — SEC 8-K summary
======================================

Issuer:     Sigyn Therapeutics, Inc. (SIGY)
CIK:        0001642159
Form:       8-K
Filed at:   2025-01-16T23:59:59+00:00
Accession:  0001493152-25-002575
Event type: leadership
Sentiment:  neutral
Materiality: 0.40
Item codes: 5.02
LLM model:  deepseek-v4-flash:cloud@v2

Sigyn Therapeutics appoints Michael Ryan to board effective Jan 11, 2025
------------------------------------------------------------------------

- Michael Ryan appointed to board; will serve until next stockholder meeting or successor elected.
- Ryan is a founder director of Irrus Investments, largest angel syndicate in Ireland, with €40M+ invested in 35 life science and tech firms.
- Compensation: $30,000 annual cash retainer plus $50,000 in restricted stock units or options, vesting quarterly over one year.
- Previously CEO of Sedana Medical (Nasdaq First North) and Artema Medical (acquired by Datascope).

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1642159/000149315225002575/0001493152-25-002575-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1642159/000149315225002575/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-25-002575

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer